制药公司警告美国-欧盟关税争端可能会抬高药品价格,破坏供应。 Pharmaceutical firms warn U.S.-EU tariff dispute could raise drug prices and disrupt supplies.

制药业警告说,美国-欧盟的关税争端可能会抬高药品价格,扰乱供应,影响病人获得药品的机会。 The pharmaceutical industry is warning that a US-EU tariff dispute could raise drug prices and disrupt supplies, affecting patient access. 工业领导人敦促两国政府将医疗物品排除在关税之外, Industry leaders are urging both governments to exclude medical goods from tariffs to keep medications affordable. Novo Nordisk和Merck等公司也在探索如何减少对欧洲生产的依赖,以降低潜在成本。 Companies like Novo Nordisk and Merck are also exploring ways to reduce their reliance on European production to mitigate potential costs.